{"url_path":"/sec/ndra/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1681682/0001213900-26-057680-index.html","accession_number":"0001213900-26-057680","cik":"0001681682","ticker":"NDRA","issuer_name":"ENDRA Life Sciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1681682/0001213900-26-057680-index.html","primary_entity_key":"0001681682","primary_entity_name":"ENDRA Life Sciences Inc."},"word_count":52,"has_tables":true,"body_markdown":"**Item 1. Legal Proceedings**\n\n \n\nWe are not currently a party to any pending legal\nproceedings that we believe will have a material adverse effect on our business or financial condition. We may, however, be subject to\nvarious claims and legal actions arising in the ordinary course of business from time to time."}